“Many congratulations to the FGIH team on obtaining UKAS ISO17025 Accreditation. A big thank you to the TQM team for all their hard work in supporting our application” – Dr Ebrahim Hoosien, CEO.
“The FGIH may be a small team, but the passion for quality and excellence in service delivery to all our clients during the pandemic, has resulted in a well-deserved stamp of approval from UKAS. I am very proud of the team and the energy we share in providing confidence in the products and services we provide” – Dr Caroline Turner, CSO.
Bowel cancer, also known as colorectal cancer, is one of the most common forms of cancer. Hereditary bowel cancer occurs when genetic mutations, passed down through families, increase a person’s risk of developing cancer in the colon or rectum.
Read the real truth behind non-invasive early baby gender testing, and the essential things to look out for before embarking on this process to ensure the most accurate result.
At home health tests are everywhere – but do they really work? Since the introduction of COVID-19 testing at home the home testing market has exploded. But, are all the promises accurate? Are we left with more questions than answers? How legitimate are they?
Thousands of people with a severe dust mite allergy are set to benefit from life-changing treatment. NICE recommends an innovative daily tablet treatment shown to reduce symptoms and improve quality of life.
Forensic Genomics Innovation Hub
Laboratory 7, First Floor
Epsilon House, Enterprise Road
Southampton Science Park
Southampton
SO16 7NS
United Kingdom
Email: lab@fgih.co.uk
Phone: (+44) 02380118980
